Cytokine and Growth Factor Reviews
Journal Impact IF - Analysis · Trend · Prediction · Ranking


New

Journal Impact IF

2019-2020

5.982

9.6%

Journal Impact IF Trend

Related Journals

Popular Journals

Cytokine and Growth Factor Reviews

The 2019-2020 Journal Impact IF of Cytokine and Growth Factor Reviews is 5.982, which is just updated in 2020.

Cytokine and Growth Factor Reviews Impact Factor
Highest IF
8.831
Highest Journal Impact IF

The highest Journal Impact IF of Cytokine and Growth Factor Reviews is 8.831.

Lowest IF
5.357
Lowest Journal Impact IF

The lowest Journal Impact IF of Cytokine and Growth Factor Reviews is 5.357.

Total Growth Rate
-23.4%
IF Total Growth Rate

The total growth rate of Cytokine and Growth Factor Reviews IF is -23.4%.

Annual Growth Rate
-2.6%
IF Annual Growth Rate

The annual growth rate of Cytokine and Growth Factor Reviews IF is -2.6%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
General Biochemistry,Genetics and Molecular Biology Q1 16/197

General Biochemistry,Genetics and Molecular Biology 92%

Immunology Q1 21/200

Immunology 89%

Immunology and Allergy Q1 19/180

Immunology and Allergy 89%

Endocrinology, Diabetes and Metabolism Q1 11/217

Endocrinology, Diabetes and Metabolism 95%

Journal Impact IF Ranking

· In the General Biochemistry,Genetics and Molecular Biology research field, the Quartile of Cytokine and Growth Factor Reviews is Q1. Cytokine and Growth Factor Reviews has been ranked #16 over 197 related journals in the General Biochemistry,Genetics and Molecular Biology research category. The ranking percentile of Cytokine and Growth Factor Reviews is around 92% in the field of General Biochemistry,Genetics and Molecular Biology.
· In the Immunology research field, the Quartile of Cytokine and Growth Factor Reviews is Q1. Cytokine and Growth Factor Reviews has been ranked #21 over 200 related journals in the Immunology research category. The ranking percentile of Cytokine and Growth Factor Reviews is around 89% in the field of Immunology.
· In the Immunology and Allergy research field, the Quartile of Cytokine and Growth Factor Reviews is Q1. Cytokine and Growth Factor Reviews has been ranked #19 over 180 related journals in the Immunology and Allergy research category. The ranking percentile of Cytokine and Growth Factor Reviews is around 89% in the field of Immunology and Allergy.
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of Cytokine and Growth Factor Reviews is Q1. Cytokine and Growth Factor Reviews has been ranked #11 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of Cytokine and Growth Factor Reviews is around 95% in the field of Endocrinology, Diabetes and Metabolism.

Cytokine and Growth Factor Reviews Impact Factor 2020-2021 Prediction

Cytokine and Growth Factor Reviews Impact Factor Predition System

Cytokine and Growth Factor Reviews Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
1153
Total Citations
140538

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 5.982
2018-2019 5.458
2017-2018 6.395
2016-2017 6.794
2015-2016 6.571
2014-2015 5.357
2013-2014 6.537
2012-2013 8.831
2011-2012 7.812
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Cytokine and Growth Factor Reviews is 5.982
· The 2018-2019 Journal Impact IF of Cytokine and Growth Factor Reviews is 5.458
· The 2017-2018 Journal Impact IF of Cytokine and Growth Factor Reviews is 6.395
· The 2016-2017 Journal Impact IF of Cytokine and Growth Factor Reviews is 6.794
· The 2015-2016 Journal Impact IF of Cytokine and Growth Factor Reviews is 6.571
· The 2014-2015 Journal Impact IF of Cytokine and Growth Factor Reviews is 5.357
· The 2013-2014 Journal Impact IF of Cytokine and Growth Factor Reviews is 6.537
· The 2012-2013 Journal Impact IF of Cytokine and Growth Factor Reviews is 8.831
· The 2011-2012 Journal Impact IF of Cytokine and Growth Factor Reviews is 7.812

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
1992 1 0
1995 1 6
1996 34 23
1997 26 264
1998 25 603
1999 19 996
2000 31 1419
2001 30 1786
2002 40 2426
2003 47 2973
2004 38 3706
2005 50 4370
2006 40 5679
2007 54 6150
2008 39 6803
2009 53 7295
2010 52 7755
2011 34 8413
2012 35 9047
2013 52 9259
2014 74 9051
2015 65 8904
2016 63 8555
2017 66 8580
2018 50 7295
2019 41 8073
2020 91 10235
2021 2 872
Publications Cites Dataset

· The Cytokine and Growth Factor Reviews has published 1 reports and received 0 citations in 1992.
· The Cytokine and Growth Factor Reviews has published 1 reports and received 6 citations in 1995.
· The Cytokine and Growth Factor Reviews has published 34 reports and received 23 citations in 1996.
· The Cytokine and Growth Factor Reviews has published 26 reports and received 264 citations in 1997.
· The Cytokine and Growth Factor Reviews has published 25 reports and received 603 citations in 1998.
· The Cytokine and Growth Factor Reviews has published 19 reports and received 996 citations in 1999.
· The Cytokine and Growth Factor Reviews has published 31 reports and received 1419 citations in 2000.
· The Cytokine and Growth Factor Reviews has published 30 reports and received 1786 citations in 2001.
· The Cytokine and Growth Factor Reviews has published 40 reports and received 2426 citations in 2002.
· The Cytokine and Growth Factor Reviews has published 47 reports and received 2973 citations in 2003.
· The Cytokine and Growth Factor Reviews has published 38 reports and received 3706 citations in 2004.
· The Cytokine and Growth Factor Reviews has published 50 reports and received 4370 citations in 2005.
· The Cytokine and Growth Factor Reviews has published 40 reports and received 5679 citations in 2006.
· The Cytokine and Growth Factor Reviews has published 54 reports and received 6150 citations in 2007.
· The Cytokine and Growth Factor Reviews has published 39 reports and received 6803 citations in 2008.
· The Cytokine and Growth Factor Reviews has published 53 reports and received 7295 citations in 2009.
· The Cytokine and Growth Factor Reviews has published 52 reports and received 7755 citations in 2010.
· The Cytokine and Growth Factor Reviews has published 34 reports and received 8413 citations in 2011.
· The Cytokine and Growth Factor Reviews has published 35 reports and received 9047 citations in 2012.
· The Cytokine and Growth Factor Reviews has published 52 reports and received 9259 citations in 2013.
· The Cytokine and Growth Factor Reviews has published 74 reports and received 9051 citations in 2014.
· The Cytokine and Growth Factor Reviews has published 65 reports and received 8904 citations in 2015.
· The Cytokine and Growth Factor Reviews has published 63 reports and received 8555 citations in 2016.
· The Cytokine and Growth Factor Reviews has published 66 reports and received 8580 citations in 2017.
· The Cytokine and Growth Factor Reviews has published 50 reports and received 7295 citations in 2018.
· The Cytokine and Growth Factor Reviews has published 41 reports and received 8073 citations in 2019.
· The Cytokine and Growth Factor Reviews has published 91 reports and received 10235 citations in 2020.
· The Cytokine and Growth Factor Reviews has published 2 reports and received 872 citations in 2021.
· The total publications of Cytokine and Growth Factor Reviews is 1153.
· The total citations of Cytokine and Growth Factor Reviews is 140538.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Cytokine and Growth Factor Reviews | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Cytokine and Growth Factor Reviews Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Cytokine and Growth Factor Reviews during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Cytokine and Growth Factor Reviews.

History

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Use

The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor

Pros:

  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
Cons:
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.

Criticism

Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Cytokine and Growth Factor Reviews
Journal Profile

About

Cytokine & Growth Factor Reviews publishes thought-provoking articles (critical reviews, state-of-the-art reviews, letters to the editor, meeting reviews) devoted to important advances in the rapidly changing fields of growth factor and cytokine research. Major emphasis is placed on the multidisciplinary significance of cytokines and growth factors in areas as diverse as signal transduction, cell growth and differentiation, embryonic development, immunology, tumorigenesis and clinical medicine. None

Highly Cited Keywords

ISSN
1359-6101
ISSN

The ISSN of Cytokine and Growth Factor Reviews is 1359-6101 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
1879-0305
ISSN (Online)

The ISSN (Online) of Cytokine and Growth Factor Reviews is 1879-0305 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Publisher
Elsevier BV
Publisher

Cytokine and Growth Factor Reviews is published by Elsevier BV .

Publication Frequency
Bimonthly
Publication Frequency

Cytokine and Growth Factor Reviews publishes reports Bimonthly .

Coverage
1990-1992, 1994-2020
Coverage

The Publication History of Cytokine and Growth Factor Reviews covers 1990-1992, 1994-2020 .

Open Access
NO
Open Access

Cytokine and Growth Factor Reviews is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Cytokine and Growth Factor Reviews. Cytokine and Growth Factor Reviews is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

Language
English
Language

The language of Cytokine and Growth Factor Reviews is English .

Country/Region
United Kingdom
Country/Region

The publisher of Cytokine and Growth Factor Reviews is Elsevier BV , which locates in United Kingdom .

Selected Articles

Full Title Authors
Full Title Authors
The tolerogenic role of IFN-γ Primož Rožman · Urban Švajger · Urban Švajger
Mechanisms and consequences of constitutive activation of integrin-linked kinase in acute myeloid leukemia Mohammed Alasseiri · Mohammed Alasseiri · Mohammed Alasseiri · Afsar U. Ahmed · Afsar U. Ahmed · Bryan R. G. Williams · Bryan R. G. Williams · Bryan R. G. Williams
The physiopathologic interplay between stem cells and tissue niche in muscle regeneration and the role of IL-6 on muscle homeostasis and diseases Laura Forcina · Carmen Miano · Antonio Musarò · Antonio Musarò · Antonio Musarò
Peripheral CD4+ T-cell changes in connective tissue diseases Krisztina Vincze · Abigel Kolonics-Farkas · Anikó Bohács · Veronika Müller · Veronika Müller
Introduction to the Special Issue: HIV Evasion of the Antiviral Response Teslin S. Sandstrom · Jonathan B. Angel · Jonathan B. Angel
Molecular regulations and therapeutic targets of Gaucher Disease Yuehong Chen · Neetu Sud · Aubryanna Hettinghouse · Chuan-ju Liu · Chuan-ju Liu
Deciphering natural control of HIV-1: A valuable strategy to achieve antiretroviral therapy termination Hamza Loucif · Steven Gouard · Xavier Dagenais-Lussier · Armstrong Murira · Simona Stäger · Cécile Tremblay · Julien van Grevenynghe · Julien van Grevenynghe
Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer Kriti Ray · Beata Ujvari · Venkata Ramana · John A. Donald · John A. Donald
The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer Thomas Garraud · Mathilde Harel · Marie-Astrid Boutet · Benoit Le Goff · Frédéric Blanchard · Frédéric Blanchard
Dermal fibroblasts—A heterogeneous population with regulatory function in wound healing Anna Stunova · Lucie Vistejnova · Lucie Vistejnova
Chemokine regulation of innate lymphoid cell tissue distribution and function Alessandra Soriani · Helena Stabile · Angela Gismondi · Angela Santoni · Giovanni Bernardini · Giovanni Bernardini
DDX3 in HIV-1 infection and sensing: A paradox Melissa Stunnenberg · Teunis B. H. Geijtenbeek · Sonja I. Gringhuis · Sonja I. Gringhuis
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome Carolina Scagnolari · Guido Antonelli · Guido Antonelli
Lymphoid tissue inducer—A divergent member of the ILC family Chao Zhong · Mingzhu Zheng · Jinfang Zhu · Jinfang Zhu
STING dependent sensing – Does HIV actually care? Christian Krapp · Kasper L. Jønsson · Martin R. Jakobsen · Martin R. Jakobsen
Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins Daniel Sauter · Frank Kirchhoff · Frank Kirchhoff
Inflammation-induced metabolic derangements or adaptation: An immunometabolic perspective Gustav van Niekerk · Anna-Mart Engelbrecht · Anna-Mart Engelbrecht
The role of the common gamma-chain family cytokines in γ δ T cell-based anti-cancer immunotherapy Heleen H. Van Acker · Diana Campillo-Davo · Gils Roex · Maarten Versteven · Evelien Smits · Viggo Van Tendeloo · Viggo Van Tendeloo
Innate lymphoid cells in organ fibrosis Giuseppe Sciumè · Giuseppe Sciumè
Interferon-associated therapies toward HIV control: The back and forth Yun Ge · Man Huang · Yong-ming Yao · Yong-ming Yao
MicroRNAs link chronic inflammation in childhood to growth impairment and insulin-resistance Roman Radetskyy · Aïcha Daher · Anne Gatignol · Anne Gatignol
Inflammation in human carotid atheroma plaques Nadia Al-Banna · Farhan S. Cyprian · M. John Albert · M. John Albert
Armed oncolytic viruses: A kick-start for anti-tumor immunity Elisa Vicenzi · Guido Poli · Guido Poli
The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection Nicolas Noel · Béatrice Jacquelin · Nicolas Huot · Cécile Goujard · Olivier Lambotte · Michaela Müller-Trutwin · Michaela Müller-Trutwin
Adiponectin: A potential therapeutic target for metabolic syndrome Kathrin Sutter · Julia Dickow · Ulf Dittmer · Ulf Dittmer
Cytokines as therapeutic agents and targets in heart disease Beatrice Zitti · Yenan T. Bryceson · Yenan T. Bryceson · Yenan T. Bryceson
Natural killer cells in inflammation and autoimmunity Stephanie Binder · Michela Luciano · Jutta Horejs-Hoeck · Jutta Horejs-Hoeck
The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators Volatiana Rakotoarivelo · Bhavesh Variya · Subburaj Ilangumaran · Marie-France Langlois · Sheela Ramanathan · Sheela Ramanathan
Inflammation in human adipose tissues–Shades of gray, rather than white and brown Rik Janssens · Sofie Struyf · Paul Proost · Paul Proost
Pathological role of the homeostatic chemokine CXCL12 Tiantian Wang · Chengqi He · Chengqi He
The involvement of plasmacytoid cells in HIV infection and pathogenesis Francesca Cirillo · Pietro Lazzeroni · Cecilia Catellani · Chiara Sartori · Sergio Amarri · Maria E. Street · Maria E. Street
Interferon α subtypes in HIV infection Alessandra Aiello · Flavia Giannessi · Zulema A. Percario · Elisabetta Affabris · Elisabetta Affabris
Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies Arundhoti Das · Christelle Harly · Qi Yang · Avinash Bhandoola · Avinash Bhandoola
The enigmatic role of IL-38 in inflammatory diseases Sidrah Naseem · Tabinda Hussain · Sobia Manzoor · Sobia Manzoor
Lineage specification in innate lymphocytes Abhijit A. Ghadge · Amrita A. Khaire · Aniket Kuvalekar · Aniket Kuvalekar
ADAR1 and PKR, interferon stimulated genes with clashing effects on HIV-1 replication Haize Goikuria · Koen Vandenbroeck · Koen Vandenbroeck · Iraide Alloza · Iraide Alloza
Cytokine responses in campylobacteriosis: Linking pathogenesis to immunity J.F. de Graaf · L. de Vor · Ron A. M. Fouchier · B G van den Hoogen · B G van den Hoogen
Let me in: Control of HIV nuclear entry at the nuclear envelope Anvita Bhargava · Xavier Lahaye · Nicolas Manel · Nicolas Manel
Cytokines 2017 in Kanazawa: Looking beyond the horizon of integrated cytokine research from the sea of Japan David Olagnier · John Hiscott · John Hiscott
TGF-β and mesenchymal stromal cells in regenerative medicine, autoimmunity and cancer Virgínea de Araújo Farias · Ana Belén Carrillo-Gálvez · Francisco Martin · Per Anderson · Per Anderson
IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets Nese Unver · Florencia McAllister · Florencia McAllister
Impact of bone marrow-derived signals on NK cell development and functional maturation Helena Stabile · Cinzia Fionda · Angela Santoni · Angela Gismondi · Angela Gismondi
Pro-inflammatory cytokines: The link between obesity and osteoarthritis Nancy Au-Yeung · Curt M. Horvath · Curt M. Horvath
Autophagy and proinflammatory cytokines: Interactions and clinical implications Yohei Mikami · Yoshiaki Takada · Yuya Hagihara · Takanori Kanai · Takanori Kanai · Takanori Kanai
Guest editorial: Innate lymphocytes: Development, homeostasis, and disease Arita Dubnika · Arita Dubnika · Martin A.C. Manoukian · Martin A.C. Manoukian · M. Rezaa Mohammadi · Mansi Bharat Parekh · Abhijit Achyut Gurjarpadhye · Mohammed Inayathullah · Viktors Dubniks · Jonathan R. T. Lakey · Jayakumar Rajadas · Jayakumar Rajadas
Role of NOD- like Receptors in Glioma Angiogenesis: Insights into future therapeutic interventions Shivanjali Saxena · Sushmita Jha · Sushmita Jha
DNA damage talks to inflammation Idan Cohen · Idan Cohen
Corrigendum toThe untold story of IFN-γ in cancer biology[Cytokine Growth Factor Rev. 31 (2016) 73–81] M. Alper Kursunel · Gunes Esendagli · Gunes Esendagli
IL-9 and Th9 cells in health and diseases—From tolerance to immunopathology Junhui Li · Junhui Li · Shuqiu Chen · Xiang Xiao · Yong Zhao · Wenjun Ding · Xian Chang Li · Xian Chang Li
Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors Barbara Seliger · Barbara Seliger
Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences Luana Calabrò · Giovanni Luca Ceresoli · Armida D’Incecco · Arnaud Scherpereel · Joachim Aerts · Michele Maio · Michele Maio
Understanding the role of SOCS signaling in neurodegenerative diseases: Current and emerging concepts Antonia Cianciulli · Rosa Calvello · Chiara Porro · Teresa Trotta · Maria Antonietta Panaro · Maria Antonietta Panaro
Cytokine signatures in hereditary fever syndromes (HFS) José Noel Ibrahim · José Noel Ibrahim · Isabelle Jéru · Jean-Claude Lecron · Myrna Medlej-Hashim · Myrna Medlej-Hashim
Role of neurotrophic factors in attention deficit hyperactivity disorder Shih-Jen Tsai · Shih-Jen Tsai · Shih-Jen Tsai
Expression and signaling of NGF in the healthy and injured retina Tarcyane Barata Garcia · Margrit Hollborn · Andreas Bringmann · Andreas Bringmann
Post-transcriptional regulation of cytokine and growth factor signaling in cancer Irina Vlasova-St. Louis · Paul R. Bohjanen · Paul R. Bohjanen
Effects of adipokines and obesity on uterine contractility Henri Azaïs · Audrey Leroy · Louise Ghesquière · Philippe Deruelle · Sandy Hanssens · Sandy Hanssens
Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue Fengna Li · Yinghui Li · Yehui Duan · Chien-An Andy Hu · Yulong Tang · Yulong Yin · Yulong Yin · Yulong Yin
Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1 Yoshikazu Takada · Yoshikazu Takada · Yoko K. Takada · Yoko K. Takada · Masaaki Fujita · Masaaki Fujita
MYC and HIF in shaping immune response and immune metabolism Jn Rashida Gnanaprakasam · John William Sherman · Ruoning Wang · Ruoning Wang
Dually modified transmembrane proteoglycans in development and disease Saeed Farajzadeh Valilou · Mahsa Keshavarz-Fathi · Mahsa Keshavarz-Fathi · Nicola Silvestris · Antonella Argentiero · Nima Rezaei · Nima Rezaei · Nima Rezaei
IL-6 signaling in diabetic nephropathy: From pathophysiology to therapeutic perspectives Eva Feigerlová · Shyue-Fang Battaglia-Hsu · Shyue-Fang Battaglia-Hsu
Fractalkine and placental growth factor: A duet of inflammation and angiogenesis in cardiovascular disorders Jolien Souffriau · Claude Libert · Claude Libert
Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: Current research and future perspectives Marta Skoda · Aleksandra Stangret · Dariusz Szukiewicz · Dariusz Szukiewicz
Orchestration of epithelial-derived cytokines and innate immune cells in allergic airway inflammation Joana Mesquita · João P. Castro-de-Sousa · Sara Vaz-Pereira · Arminda Neves · L. A. Passarinha · Cândida T. Tomaz · Cândida T. Tomaz
Pathophysiology of IL-33 and IL-17 in allergic disorders Rinkesh Kumar Gupta · Kriti Gupta · Premendra D. Dwivedi · Premendra D. Dwivedi
Nuclear sirtuins and inflammatory signaling pathways Keila Lopes Mendes · Keila Lopes Mendes · Deborah de Farias Lelis · Sérgio Henrique Sousa Santos · Sérgio Henrique Sousa Santos · Sérgio Henrique Sousa Santos
The potential role of leptin in tumor invasion and metastasis Amitabha Ray · Margot P. Cleary · Margot P. Cleary
Innovative Therapy, Monoclonal Antibodies and Beyond M. Di Nicola · L. Apetoh · Matteo Bellone · Mario P. Colombo · Gianpietro Dotti · Soldano Ferrone · M. Muscolini · J. Hiscott · Andrea Anichini · Serenella M. Pupa · F.de Braud · M. Del Vecchio · M. Del Vecchio
The JAK/STAT signaling pathway and photobiomodulation in chronic wound healing Sandy Winfield Jere · Nicolette N. Houreld · Nicolette N. Houreld
Interleukin 4/13 receptors: An overview of genes, expression and functional role in teleost fish A. Sequeida · K. Maisey · M. Imarai · M. Imarai
Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression David M. Dolivo · Sara A. Larson · Tanja Dominko · Tanja Dominko
Rush to the fire: FGF21 extinguishes metabolic stress, metaflammation and tissue damage Yongde Luo · Yongde Luo · Sheng Ye · Xiong Chen · Fanghua Gong · Weiqin Lu · Xiaokun Li · Xiaokun Li
Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases Alok Kumar Verma · Murli Manohar · Sathisha Upparahalli Venkateshaiah · Anil Mishra · Anil Mishra
Interaction of the innate immune system with positive-strand RNA virus replication organelles Enzo Maxim Scutigliani · Marjolein Kikkert · Marjolein Kikkert
Mechanistic insights into the protective impact of zinc on sepsis Laura M. Jenkins · Ben Horst · Carly L. Lancaster · Karthikeyan Mythreye · Karthikeyan Mythreye
Cytokines and cytokine networks target neurons to modulate long-term potentiation G. Aleph Prieto · Carl W. Cotman · Carl W. Cotman
Immunotherapy targeting immune check-point(s) in brain metastases Anna Maria Di Giacomo · Monica Valente · Alessia Covre · Riccardo Danielli · Michele Maio · Michele Maio
Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors Floris Dammeijer · Sai Ping Lau · Casper H.J. van Eijck · Sjoerd H. van der Burg · Joachim Aerts · Joachim Aerts
Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting Antonella Sistigu · Francesca Di Modugno · Gwenola Manic · Paola Nisticò · Paola Nisticò
GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism Shreeram C. Nallar · Dhan V. Kalvakolanu · Dhan V. Kalvakolanu
Harnessing the CD1 restricted T cell response for leukemia adoptive immunotherapy Michela Consonni · Claudia de Lalla · Alessandra Bigi · Paolo Dellabona · Giulia Casorati · Giulia Casorati
Dysfunctional T cell metabolism in the tumor microenvironment Kathryn E. Beckermann · Stephanie O. Dudzinski · Jeffrey C. Rathmell · Jeffrey C. Rathmell
Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism Veronica De Rosa · Francesca Di Rella · Antonio Di Giacomo · Giuseppe Matarese · Giuseppe Matarese
Glucocorticoid resistance as a major drive in sepsis pathology Karen Dendoncker · Claude Libert · Claude Libert
Metabolic regulation of suppressive myeloid cells in cancer Antonio Sica · Laura Strauss · Francesca Maria Consonni · Cristina Travelli · Armando A. Genazzani · Chiara Porta · Chiara Porta
Amino-acid sensing and degrading pathways in immune regulation Ursula Grohmann · Giada Mondanelli · Maria Laura Belladonna · Ciriana Orabona · Maria Teresa Pallotta · Alberta Iacono · Paolo Puccetti · Claudia Volpi · Claudia Volpi
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma Luigi Fattore · Andrea Sacconi · Rita Mancini · Gennaro Ciliberto · Gennaro Ciliberto
Control of B lymphocyte development and functions by the mTOR signaling pathways Terri N. Iwata · Julita A. Ramírez-Komo · Heon Park · Brian M. Iritani · Brian M. Iritani
Tumor-derived factors affecting immune cells Vincenzo C. Russo · Maria Pia Protti · Maria Pia Protti
Improving homing in T cell therapy Debora Vignali · Marinos Kallikourdis · Marinos Kallikourdis
The added value of type i interferons to cytotoxic treatments of cancer Laura Bracci · Antonella Sistigu · Enrico Proietti · Federica Moschella · Federica Moschella
New vaccination strategies in liver cancer Luigi Buonaguro · Luigi Buonaguro
Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancer Matteo Bellone · Angela Rita Elia · Angela Rita Elia
The interplay between histone deacetylases and rho kinases is important for cancer and neurodegeneration Sonja Mertsch · Oliver H. Krämer · Oliver H. Krämer
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells Elisa Cappuzzello · Roberta Sommaggio · Paola Zanovello · Antonio Rosato · Antonio Rosato
Effects of interleukin-1beta polymorphisms on brain function and behavior in healthy and psychiatric disease conditions Shih-Jen Tsai · Shih-Jen Tsai · Shih-Jen Tsai
Molecular structure and differential function of choline kinases CHKα and CHKβ in musculoskeletal system and cancer Xi Chen · Xi Chen · Xi Chen · Heng Qiu · Chao Wang · Yu Yuan · Yu Yuan · Jennifer Tickner · Jiake Xu · Jiake Xu · Jun Zou · Jun Zou
Curcumin as a natural regulator of monocyte chemoattractant protein-1 Maryam Saberi Karimian · Matteo Pirro · Muhammed Majeed · Amirhossein Sahebkar · Amirhossein Sahebkar
Bone morphogenetic protein-2 and tumor growth: Diverse effects and possibilities for therapy Haijun Tian · Jie Zhao · Elsa J. Brochmann · Jeffrey C. Wang · Samuel S. Murray · Samuel S. Murray
Role of leptin as a link between metabolism and the immune system Antonio Pérez-Pérez · Teresa Vilariño-García · Patricia Fernández-Riejos · Jenifer Martín-González · Juan J. Segura-Egea · Víctor Sánchez-Margalet · Víctor Sánchez-Margalet
The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma Fernanda Costa Brandão Berti · Ana Paula Lombardi Pereira · Guilherme Cesar Martelossi Cebinelli · Kleber Paiva Trugilo · Karen Brajão de Oliveira · Karen Brajão de Oliveira
Cytokines in the pathogenesis of hemophilic arthropathy Piotr Wojdasiewicz · Łukasz A. Poniatowski · Paweł Nauman · Tomasz Mandat · Agnieszka Paradowska-Gorycka · Katarzyna Romanowska-Próchnicka · Dariusz Szukiewicz · Andrzej Kotela · Andrzej Kotela · Łukasz Kubaszewski · Ireneusz Kotela · Iwona Kurkowska-Jastrzębska · Robert Gasik · Robert Gasik
Immunobiology of the IL-15/IL-15Rα complex as an antitumor and antiviral agent Yin Guo · Yin Guo · Liming Luan · Naeem K. Patil · Edward R. Sherwood · Edward R. Sherwood · Edward R. Sherwood
Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication Teslin S. Sandstrom · Teslin S. Sandstrom · Nischal Ranganath · Nischal Ranganath · Jonathan B. Angel · Jonathan B. Angel · Jonathan B. Angel · Jonathan B. Angel
Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions Lorena Pérez · Lorena Pérez · Natalia Muñoz-Durango · Claudia A. Riedel · Claudia A. Riedel · César Echeverría · Alexis M. Kalergis · Alexis M. Kalergis · Claudio Cabello-Verrugio · Claudio Cabello-Verrugio · Felipe Simon · Felipe Simon · Felipe Simon
Cytokine expression levels in ALS: A potential link between inflammation and BMAA-triggered protein misfolding Nara Michaelson · Nara Michaelson · Dominic N. Facciponte · Walter G. Bradley · Elijah W. Stommel · Elijah W. Stommel · Elijah W. Stommel
2017 Keystone Symposia at the Fairmont Banff Springs: Exploring new concepts in innate immunity and interferon signaling at the haunted castle Camilla Gunderstofte · Christian K. Holm · David Olagnier · David Olagnier
Targeting the tumor and its associated stroma: One and one can make three in adoptive T cell therapy of solid tumors Anna Mondino · Gerlanda Vella · Laura Icardi · Laura Icardi
Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT) Vincenzo C. Russo · Alberto Amadori · Marco Bregni · Luana Calabrò · Mario P. Colombo · Massimo Di Nicola · Pier Francesco Ferrucci · Enrico Proietti · Michele Maio · Matteo Bellone · Matteo Bellone
Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes Javier Donate-Correa · Ernesto Martín-Núñez · Nayra Pérez Delgado · Mercedes Muros de Fuentes · Alberto Ortiz Arduan · Carmen Mora-Fernández · Juan F. Navarro González · Juan F. Navarro González
Actions from head to toe: An update on Bone/Body Morphogenetic Proteins in health and disease Christian Hiepen · Christian Hiepen · David Yadin · David Yadin · Paul Rikeit · Paul Rikeit · Gina Dörpholz · Petra Knaus · Petra Knaus · Petra Knaus
T helper 2 and T follicular helper cells: Regulation and function of interleukin-4 Anupama Sahoo · Anupama Sahoo · Shradha Wali · Shradha Wali · Roza Nurieva · Roza Nurieva · Roza Nurieva
The PDGF system and its antagonists in liver fibrosis Erawan Borkham-Kamphorst · Ralf Weiskirchen · Ralf Weiskirchen
IL-9 signaling as key driver of chronic inflammation in mucosal immunity Markus F. Neurath · Susetta Finotto · Susetta Finotto
Beyond autophagy: New roles for ULK1 in immune signaling and interferon responses Diana Saleiro · Ewa M. Kosciuczuk · Leonidas C. Platanias · Leonidas C. Platanias
Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box Zaheer Ul-Haq · Sehrish Naz · M. Ahmed Mesaik · M. Ahmed Mesaik · M. Ahmed Mesaik
The implication of SUMO in intrinsic and innate immunity Zara Hannoun · Ghizlane Maarifi · Mounira K. Chelbi-Alix · Mounira K. Chelbi-Alix
STAT3 signaling in immunity Emily J. Hillmer · Huiyuan Zhang · Haiyan S. Li · Stephanie S. Watowich · Stephanie S. Watowich · Stephanie S. Watowich
A gradient of glucocorticoid sensitivity among helper T cell cytokines Jesus Banuelos · Nicholas Z. Lu · Nicholas Z. Lu
Current topics in HIV pathogenesis, part 2: Inflammation drives a Warburg-like effect on the metabolism of HIV-infected subjects Mouna Aounallah · Xavier Dagenais-Lussier · Mohamed El-Far · Vikram Mehraj · Mohammad-Ali Jenabian · Jean-Pierre Routy · Julien van Grevenynghe · Julien van Grevenynghe
New insights into CD4+ T cell abnormalities in systemic sclerosis Mengguo Liu · Wenyu Wu · Xinfen Sun · Ji Yang · Jinhua Xu · Wenwen Fu · Ming Li · Ming Li
Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response Monika Majchrzak-Gorecka · Pawel Majewski · Beata Grygier · Krzysztof Murzyn · Joanna Cichy · Joanna Cichy
Structural insights into BMP receptors: Specificity, activation and inhibition David Yadin · David Yadin · Petra Knaus · Petra Knaus · Thomas D. Mueller · Thomas D. Mueller
Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders Maurizio Pacifici · Eileen M. Shore · Eileen M. Shore
The cytokine-serum amyloid A-chemokine network Mieke De Buck · Mieke Gouwy · Ji Ming Wang · Jacques Van Snick · Paul Proost · Sofie Struyf · Jozef Van Damme · Jozef Van Damme
Endocytosis and trafficking of BMP receptors: Regulatory mechanisms for fine-tuning the signaling response in different cellular contexts Marcelo Ehrlich · Marcelo Ehrlich
Bone morphogenetic proteins in inflammation, glucose homeostasis and adipose tissue energy metabolism Lovorka Grgurevic · Gitte Lund Christensen · Tim J. Schulz · Slobodan Vukicevic · Slobodan Vukicevic
Tuning cellular responses to BMP-2 with material surfaces Elisa Migliorini · Elisa Migliorini · Anne Valat · Anne Valat · Anne Valat · Catherine Picart · Catherine Picart · Elisabetta Ada Cavalcanti-Adam · Elisabetta Ada Cavalcanti-Adam · Elisabetta Ada Cavalcanti-Adam
Mechanisms of action of bone morphogenetic proteins in cancer Hayley Davis · Erna Raja · Kohei Miyazono · Yutaro Tsubakihara · Yutaro Tsubakihara · Aristidis Moustakas · Aristidis Moustakas · Aristidis Moustakas
Common mechanisms in development and disease: BMP signaling in craniofacial development Daniel Graf · Zeba Malik · Satoru Hayano · Satoru Hayano · Yuji Mishina · Yuji Mishina
BMP morphogen gradients in flies Shinya Matsuda · Stefan Harmansa · Markus Affolter · Markus Affolter
E2F1 transcription factor and its impact on growth factor and cytokine signaling Mustafa Gokhan Ertosun · Fatma Zehra Hapil · Ozes Osman Nidai · Ozes Osman Nidai
BMP-SMAD signaling: From pluripotent stem cells to cardiovascular commitment Valeria V. Orlova · Susana Lopes · Susana Lopes · Gudrun Valdimarsdottir · Gudrun Valdimarsdottir
S100A7: A rAMPing up AMP molecule in psoriasis Fabio D’Amico · Evangelia Skarmoutsou · Mariagrazia Granata · Chiara Trovato · Giulio A. Rossi · Maria Clorinda Mazzarino · Maria Clorinda Mazzarino
Monocyte and interferon based therapy for the treatment of ovarian cancer Daniel S. Green · Ana T. Nunes · Christina M. Annunziata · Kathryn C. Zoon · Kathryn C. Zoon
Chemokine binding proteins: An immunomodulatory strategy going viral Víctor González-Motos · Kai A. Kropp · Abel Viejo-Borbolla · Abel Viejo-Borbolla
Interleukin 15: A key cytokine for immunotherapy Manoj Patidar · Naveen Yadav · Sarat K. Dalai · Sarat K. Dalai
New polyprenyl phosphate based preparation Fortepren® as promising cytokine regulationg antiviral remedy Alexander V. Pronin · Alexander N. Narovlyansky · Andrey E. Shulzhenko · Alexander Vladimirovich Sanin · Alexander M. Sedov · Alexander M. Sedov
The CXCL8-CXCR1/2 pathways in cancer Qian Liu · Anping Li · Yijun Tian · Jennifer D. Wu · Yu Liu · Tengfei Li · Yuan Chen · Xinwei Han · Kongming Wu · Kongming Wu
Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders Alma Y. Galvez-Contreras · Tania Campos-Ordonez · Veronica Lopez-Virgen · Jesus Gomez-Plascencia · Rodrigo Ramos-Zúñiga · Oscar Gonzalez-Perez · Oscar Gonzalez-Perez
Understanding Interferon Subtype Therapy for Viral Infections: Harnessing the Power of the Innate Immune System Cassandra M. Berry · Cassandra M. Berry
Role of interleukin-18 in the pathophysiology of allergic diseases Nathan L Sanders · Anil Mishra · Anil Mishra
The untold story of IFN-γ in cancer biology M. Alper Kursunel · Gunes Esendagli · Gunes Esendagli
Post-translational regulation of RORγt-A therapeutic target for the modulation of interleukin-17-mediated responses in autoimmune diseases Sascha Rutz · Céline Eidenschenk · James R. Kiefer · Wenjun Ouyang · Wenjun Ouyang
Endocytic regulation of cytokine receptor signaling Jarosław Cendrowski · Agnieszka Mamińska · Marta Miaczynska · Marta Miaczynska
A panoramic review and in silico analysis of IL-11 structure and function Navid Nezafat · Younes Ghasemi · Younes Ghasemi
Chemokine regulation of neutrophil function in tumors Ornella Bonavita · Matteo Massara · Raffaella Bonecchi · Raffaella Bonecchi
IFN-β differentially regulates the function of T cell subsets in MS and EAE Nadia Kavrochorianou · Melina Markogiannaki · Sylva Haralambous · Sylva Haralambous
The IL-17A/IL-17RA axis in pulmonary defence and immunopathology Nicola Ivan Lorè · Alessandra Bragonzi · Cristina Cigana · Cristina Cigana
The emerging role of interferon regulatory factor 9 in the antiviral host response and beyond Tamara Suprunenko · Markus J. Hofer · Markus J. Hofer
The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses Katarzyna Blaszczyk · Hanna Nowicka · Kaja Kostyrko · Aleksandra Antonczyk · Joanna Wesoly · Hans A.R. Bluyssen · Hans A.R. Bluyssen
Regulation of TBK1 activity by Optineurin contributes to cell cycle-dependent expression of the interferon pathway Robert Weil · Emmanuel Laplantine · Pierre Génin · Pierre Génin
What can pestiviral endonucleases teach us about innate immunotolerance Carmela Lussi · Matthias Schweizer · Matthias Schweizer
CD28 costimulatory signals in T lymphocyte activation: Emerging functions beyond a qualitative and quantitative support to TCR signalling Nicla Porciello · Loretta Tuosto · Loretta Tuosto
HES1 in immunity and cancer Aradhana Rani · Aradhana Rani · Roseanna Greenlaw · Richard Smith · Christine Galustian · Christine Galustian
Microbial pathogenesis and type III interferons Taylor S. Cohen · Dane Parker · Dane Parker
Stimulator of interferon genes (STING): Anew chapterin virus-associated cancer research. Lessons from wild-derived mouse models of innate immunity Alexander Poltorak · Alexander Poltorak · Olga V. Kurmyshkina · Tatyana O. Volkova · Tatyana O. Volkova
The transcription factor BATF modulates cytokine-mediated responses in T cells Nina Sopel · Anna Graser · Stephanie Mousset · Susetta Finotto · Susetta Finotto
Novel interferonopathies associated with mutations in RIG-I like receptors Insa Buers · Yvonne Nitschke · Frank Rutsch · Frank Rutsch
RNase L and the NLRP3-inflammasome: An old merchant in a new trade Shuvojit Banerjee · Shuvojit Banerjee
FGF10: A multifunctional mesenchymal-epithelial signaling growth factor in development, health, and disease Nobuyuki Itoh · Nobuyuki Itoh
Antimicrobial potentials and structural disorder of human and animal defensins Ehab H. Mattar · Hussein A. Almehdar · Haitham A. Yacoub · Vladimir N. Uversky · Vladimir N. Uversky · Vladimir N. Uversky · Elrashdy M. Redwan · Elrashdy M. Redwan
The role of adiponectin in obesity-associated female-specific carcinogenesis Ganji Purnachandra Nagaraju · Ganji Purnachandra Nagaraju · Balney Rajitha · Balney Rajitha · Sheik Aliya · Rama P. Kotipatruni · Appiya Santharam Madanraj · Anthea Hammond · Dongkyoo Park · Srinivasulu Chigurupati · Afroz Alam · Subasini Pattnaik · Subasini Pattnaik
BMP signaling in vascular biology and dysfunction Amaya García de Vinuesa · Salim Abdelilah-Seyfried · Salim Abdelilah-Seyfried · Petra Knaus · An Zwijsen · Sabine Bailly · Sabine Bailly · Sabine Bailly
Molecular mechanisms of curcumins suppressing effects on tumorigenesis, angiogenesis and metastasis, focusing on NF-κB pathway Yunes Panahi · Behrad Darvishi · Behrad Darvishi · Mostafa Ghanei · Narges Jowzi · Narges Jowzi · Fatemeh Beiraghdar · Behrang Shiri Varnamkhasti · Behrang Shiri Varnamkhasti · Behrang Shiri Varnamkhasti
A critical role of interleukin-1 in preterm labor Mathieu Nadeau-Vallée · Dima Obari · Christiane Quiniou · William D. Lubell · David M. Olson · Sylvie Girard · Sylvain Chemtob · Sylvain Chemtob
BMPs in bone regeneration: Less is more effective, a paradigm-shift $ Katharina Schmidt-Bleek · Bettina M. Willie · Bettina M. Willie · P. Schwabe · Petra Seemann · Georg N. Duda · Georg N. Duda
The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer Jens Geginat · Paola Larghi · Moira Paroni · Giulia Nizzoli · Alessandra Penatti · Massimiliano Pagani · Nicola Gagliani · Nicola Gagliani · Pier Luigi Meroni · Sergio Abrignani · Richard A. Flavell · Richard A. Flavell · Richard A. Flavell
Opposing roles of IL-10 in acute bacterial infection Hernán F. Peñaloza · Bárbara M. Schultz · Pamela A. Nieto · Geraldyne A. Salazar · Isidora Suazo · Pablo A. González · Claudia A. Riedel · Manuel Alvarez-Lobos · Alexis M. Kalergis · Alexis M. Kalergis · Susan M. Bueno · Susan M. Bueno · Susan M. Bueno
Inflammatory microenvironment and human papillomavirus-induced carcinogenesis Giorgio Mangino · Maria Vincenza Chiantore · Marco Iuliano · Gianna Fiorucci · Giovanna Romeo · Giovanna Romeo · Giovanna Romeo
Brain heterogeneity leads to differential innate immune responses and modulates pathogenesis of viral infections Loreen Zegenhagen · Chaitanya Kurhade · Nikolaus Koniszewski · Anna K. Överby · Andrea Kröger · Andrea Kröger

The tolerogenic role of IFN-γ
Cytokine and Growth Factor Reviews | 2018
Primož Rožman · Urban Švajger · Urban Švajger
Mechanisms and consequences of constitutive activation of integrin-linked kinase in acute myeloid leukemia
Cytokine and Growth Factor Reviews | 2018
Mohammed Alasseiri · Mohammed Alasseiri · Mohammed Alasseiri · Afsar U. Ahmed · Afsar U. Ahmed · Bryan R. G. Williams · Bryan R. G. Williams · Bryan R. G. Williams
Peripheral CD4+ T-cell changes in connective tissue diseases
Cytokine and Growth Factor Reviews | 2018
Krisztina Vincze · Abigel Kolonics-Farkas · Anikó Bohács · Veronika Müller · Veronika Müller